Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
about
When less may be more: calorie restriction and response to cancer therapy.Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy.Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.Anticancer effects of the microbiome and its products.Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.Considerations for successful cancer immunotherapy in aged hosts.Protective effects of short-term dietary restriction in surgical stress and chemotherapy.HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.Autophagy in natural and therapy-driven anticancer immunosurveillance.Nutrition, inflammation and cancer.Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells.Differentiation impairs Bach1 dependent HO-1 activation and increases sensitivity to oxidative stress in SH-SY5Y neuroblastoma cells.Commentary: Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor CytotoxicityStarving leukemia to induce differentiation.Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.Immune by Heart: Unexpected Observations Inspiring Perspective Therapeutic/Preventive Strategies against Cancer.Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness.Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy.Obesity and the tumor microenvironment.Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer.Understanding the tumor immune microenvironment (TIME) for effective therapy.Heme oxygenase inhibition in cancers: possible tools and targets.Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.Pushing the Limits of Cancer Therapy: The Nutrient Game.Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells.Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
P2860
Q33721921-0D8507BB-AF66-4866-AD01-71BF594534CBQ36328064-E303E8F2-EDF1-491E-AABB-AF375095B595Q37701461-663B376E-7A0E-4CBA-A31B-AB739BCC6E3BQ38681126-EA21FFCE-3B18-4119-946D-0A534FEE0156Q38726681-3EF0FA3B-9FBB-4BEE-BEE8-70924B48577FQ38792334-69047031-57BD-4E86-AC48-20D0AEE4CBBCQ38795278-C07F7957-B04D-4F1B-894B-0A0A3B1C0A5DQ38815953-40EC04F2-EAEA-432C-866A-D50A67FBC3BEQ39143259-BC8477BF-4E15-42F4-ABC3-4209BC8090B9Q39285687-7A954677-EC50-4345-92CF-1CE3739E950EQ39321120-5A7F8F6E-874C-4183-8903-C7F2351F317BQ39361915-4120D895-F3B9-40FE-AF95-8D0B05411D61Q39443978-9B06A56F-2D38-4832-83B7-DE31C554246DQ41144675-E54F62D3-77A1-494B-9FCF-AAC8B819F914Q41309443-9BD9277C-0F92-4D5E-80B0-2C16AAD5EBB0Q42227749-F1D3F060-619F-4189-B7C1-DC5E3A8102BBQ42322662-B4AA88DC-8E61-4CBB-9BC9-B5A8D0C834D0Q46082155-1E70D765-283B-4B72-BE34-034E055241F1Q47379404-33F9F5F3-3A9B-4C90-963D-84E87D3210EAQ47897624-46349CAE-E49B-46D3-A793-BF02969B9314Q48638999-266EBCDA-B601-4524-BBAA-A38B63FC2BCDQ49387706-82E01E38-8445-4EAF-8BC6-E048390A970FQ50020477-34EC2CCC-CA82-4A07-BA2A-62FCDD105D55Q52311744-B5BEC5EA-498B-4441-A2A7-578410D96586Q52431393-B9E7D13F-5399-4788-9939-EEB393C7D665Q52587537-1200E4D9-EF95-42AB-97B9-8A5C3384B726Q52597550-9EF00203-B2D8-40AA-BAEA-814E00E282D1Q54959664-7AE7F0AF-1BE8-482E-86AB-587629B08503Q55177250-4CB4104A-E17F-4588-B75F-28456FC7D40DQ56594845-C7F41E68-C7F4-4D75-AC66-9A692B4451E2
P2860
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@ast
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@en
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@nl
type
label
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@ast
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@en
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@nl
prefLabel
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@ast
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@en
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@nl
P2093
P2860
P1433
P1476
Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity.
@en
P2093
Alejandro Martin-Montalvo
Brianna Manes
Changhan Lee
Chia-Wei Cheng
Mafalda Cacciottolo
Rafael de Cabo
Roberta Buono
Sebastian Brandhorst
Stefano Di Biase
Todd E Morgan
P2860
P304
P356
10.1016/J.CCELL.2016.06.005
P50
P577
2016-07-01T00:00:00Z